Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 834

1.

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Vemuri P, Weigand SD, Przybelski SA, Knopman DS, Smith GE, Trojanowski JQ, Shaw LM, Decarli CS, Carmichael O, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2011 May;134(Pt 5):1479-92. doi: 10.1093/brain/awr049. Epub 2011 Apr 7.

PMID:
21478184
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.

Murray AD, Staff RT, McNeil CJ, Salarirad S, Ahearn TS, Mustafa N, Whalley LJ.

Brain. 2011 Dec;134(Pt 12):3687-96. doi: 10.1093/brain/awr259. Epub 2011 Nov 18.

PMID:
22102649
[PubMed - indexed for MEDLINE]
Free Article
3.

A data-driven model of biomarker changes in sporadic Alzheimer's disease.

Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, Schott JM, Alexander DC; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2014 Sep;137(Pt 9):2564-77. doi: 10.1093/brain/awu176. Epub 2014 Jul 9.

PMID:
25012224
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

PMID:
20935035
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):287-93. doi: 10.1212/WNL.0b013e3181af79e5.

PMID:
19636048
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
[PubMed - indexed for MEDLINE]
7.

Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.

Querbes O, Aubry F, Pariente J, Lotterie JA, Démonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Aug;132(Pt 8):2036-47. doi: 10.1093/brain/awp105. Epub 2009 May 12.

PMID:
19439419
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.

Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW.

Eur Neurol. 2011;66(2):75-82. doi: 10.1159/000329277. Epub 2011 Jul 22.

PMID:
21778730
[PubMed - indexed for MEDLINE]
9.

Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.

Arenaza-Urquijo EM, Molinuevo JL, Sala-Llonch R, Solé-Padullés C, Balasa M, Bosch B, Olives J, Antonell A, Lladó A, Sánchez-Valle R, Rami L, Bartrés-Faz D.

J Alzheimers Dis. 2013;35(4):715-26. doi: 10.3233/JAD-121906.

PMID:
23481686
[PubMed - indexed for MEDLINE]
10.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

PMID:
19636049
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

PMID:
19339253
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Longitudinal change of biomarkers in cognitive decline.

Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Oct;68(10):1257-66. doi: 10.1001/archneurol.2011.123. Epub 2011 Jun 13.

PMID:
21670386
[PubMed - indexed for MEDLINE]
13.

White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.

Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S124-31. doi: 10.1016/j.jalz.2012.11.009. Epub 2013 Jan 30.

PMID:
23375566
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Kreisl WC, Lyoo CH, McGwier M, Snow J, Jenko KJ, Kimura N, Corona W, Morse CL, Zoghbi SS, Pike VW, McMahon FJ, Turner RS, Innis RB; Biomarkers Consortium PET Radioligand Project Team.

Brain. 2013 Jul;136(Pt 7):2228-38. doi: 10.1093/brain/awt145. Epub 2013 Jun 17.

PMID:
23775979
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.

Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2010 Mar;67(3):308-16. doi: 10.1002/ana.21953.

PMID:
20373342
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age.

van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, Admiraal-Behloul F, Bollen EL, Westendorp RG, van Buchem MA.

Dement Geriatr Cogn Disord. 2005;20(2-3):82-8. Epub 2005 May 23.

PMID:
15942197
[PubMed - indexed for MEDLINE]
17.

Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.

Rodriguez MJ, Potter E, Shen Q, Barker W, Greig-Custo M, Agron J, Loewenstein D, Duara R.

Alzheimers Dement. 2012 May;8(3):211-8. doi: 10.1016/j.jalz.2011.04.008.

PMID:
22546353
[PubMed - indexed for MEDLINE]
18.

Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.

Solé-Padullés C, Lladó A, Bartrés-Faz D, Fortea J, Sánchez-Valle R, Bosch B, Antonell A, Molinuevo JL, Rami L.

Psychiatry Res. 2011 Jun 30;192(3):140-6. doi: 10.1016/j.pscychresns.2010.12.001. Epub 2011 May 4.

PMID:
21546220
[PubMed - indexed for MEDLINE]
19.

CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.

Fellgiebel A, Kojro E, Müller MJ, Scheurich A, Schmidt LG, Fahrenholz F.

J Geriatr Psychiatry Neurol. 2009 Mar;22(1):3-9. doi: 10.1177/0891988708327810. Epub 2008 Dec 10.

PMID:
19073834
[PubMed - indexed for MEDLINE]
20.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

PMID:
16854944
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk